Prescribe an SSRI as First-Line Treatment
For this 69-year-old woman with depression and no prior psychiatric medication use, start with an SSRI such as sertraline 25-50 mg daily, citalopram 10 mg daily, or escitalopram 10 mg daily. These agents have equivalent efficacy but favorable tolerability profiles in older adults 1.
Rationale for SSRI Selection
The American College of Physicians guideline establishes that second-generation antidepressants should be selected based on adverse effect profiles, cost, and patient preferences rather than efficacy differences, as no clinically significant differences exist among SSRIs, SNRIs, or other second-generation antidepressants for treating major depression 1. All show similar improvements in quality of life, work functioning, and depressive symptoms 1.
Specific Agent Recommendations for Older Adults
Sertraline, citalopram, and escitalopram are preferred in elderly patients because:
Sertraline (25-50 mg daily, max 200 mg): Well-tolerated with less effect on metabolism of other medications compared to other SSRIs 2. Higher rate of diarrhea but otherwise favorable profile 1.
Citalopram (10 mg daily, max 40 mg): Well-tolerated; some patients experience nausea and sleep disturbances 2. Note the 40 mg maximum dose due to QT prolongation risk in older adults.
Escitalopram (10 mg daily, max 20 mg): Showed slight statistical superiority over citalopram but clinical significance is doubtful 1.
Agents to Avoid or Use Cautiously
Paroxetine should be avoided as it has higher anticholinergic effects and significantly higher rates of sexual dysfunction than other SSRIs 2, 1. This is particularly problematic in older adults who are more sensitive to anticholinergic side effects.
Fluoxetine has a very long half-life and is more activating, with side effects potentially not manifesting for weeks 2. This makes dose adjustments difficult in older patients.
Dosing Strategy for Older Adults
Start at half the typical adult starting dose and titrate slowly:
- Increase dosage using increments of the initial dose every 5-7 days until therapeutic benefits or significant side effects appear 2
- Many older patients ultimately need the same doses as younger adults for efficacy 3
- A full therapeutic trial requires 4-8 weeks before assessing response 2
Critical Safety Monitoring
Monitor for these specific adverse events in older adults:
- Hyponatremia: SSRIs increase this risk, particularly in elderly patients 1
- Falls risk: Due to dizziness, somnolence (common side effects) 1
- GI symptoms: Nausea is the most common reason for discontinuation 1
- Suicidality: SSRIs carry increased risk for nonfatal suicide attempts, though not completed suicide 1
Alternative First-Line Option: Mirtazapine
If the patient has prominent insomnia or poor appetite, consider mirtazapine 7.5 mg at bedtime (max 30 mg) 2, 1. It is:
- Potent and well-tolerated
- Promotes sleep, appetite, and weight gain
- Has faster onset of action than SSRIs (statistically significant improvement within 2-4 weeks vs 4-8 weeks) 1
However, weight gain may be undesirable in some patients.
What NOT to Use Initially
Avoid tricyclic antidepressants (nortriptyline, desipramine) as first-line despite their inclusion in older guidelines 2. They carry higher risks of:
- Cardiotoxicity
- Orthostatic hypotension
- Anticholinergic effects (confusion, urinary retention, constipation)
- Tachycardia
These are particularly dangerous in a 69-year-old patient.
Avoid bupropion initially unless the patient has significant apathy or fatigue, as it is activating and contraindicated if seizure history exists 2.
Duration and Reassessment
- Continue antidepressant for at least 9 months after response 2
- After 9 months, attempt dosage reduction to reassess need for continued medication 2
- Discontinue over 10-14 days to limit withdrawal symptoms 2
- 38% of patients do not respond to initial treatment within 6-12 weeks 1
If First-Line Treatment Fails
If inadequate response after 6-8 weeks at therapeutic dose: